World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Food & Drink

Published Study Shows Clinically Significant Energy, Performance, and Metabolic Benefits of FutureCeuticals’ Caffinity™

Cision PR Newswire by Cision PR Newswire
June 10, 2026
in Press Releases - Food & Drink
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

MOMENCE, Ill., June 10, 2026 /PRNewswire/ — FutureCeuticals, Inc. is pleased to announce the peer-reviewed publication of clinical research demonstrating unique energy, performance, and metabolic benefits of Caffinity™, a proprietary ingredient derived from the Arabica coffee cherry (bean and fruit). This study, conducted by recognized experts in energy metabolism at the University of Exeter (UK), establishes Caffinity as the only clinically validated energy ingredient to deliver a natural complex of caffeine and polyphenols from coffee fruit, enhancing athletic performance and metabolic recovery, while avoiding some of the known downsides from functional doses of caffeine.

(PRNewsfoto/FutureCeuticals, Inc.)

In the double-blind, placebo-controlled study, a 286mg dose of Caffinity (providing 200mg of caffeine along with coffee fruit polyphenols) significantly improved time trial performance in trained cyclists, yielding a nearly 5% average increase in total work performed compared to placebo (P < 0.05). Participants also reported reduced perceived exertion during a preceding bout of sub-maximal steady-state exercise, highlighting benefits across a range of exercise intensity.

Researchers observed additional unexpected outcomes, perhaps attributable to Caffinity’s unique composition. Caffinity stimulated an increase in fat mobilization and ketone availability during recovery, priming the body for enhanced metabolic flexibility. Caffinity also helped stabilize blood glucose, avoiding the spikes and crashes often associated with functional caffeine doses and intra-exercise fueling. Despite higher work output, post-exercise lactate cleared more rapidly, returning to baseline sooner and promoting quicker recovery.

“These results support our commitment to deliver clean, science-backed, low-dosed energy solutions that meet the needs of today’s active consumer,” said J. Randal Wexler, General Counsel and VP of R&D at FutureCeuticals. “Caffinity not only enhances performance, it also demonstrates better metabolic recovery and glucose stability than typically associated with functional doses of caffeine.” Mr. Wexler concluded, “For athletes looking to optimize their performance nutrition strategies, Caffinity is a new tool to reduce stimulant exposure without sacrificing results.”

Caffinity is made from sustainably sourced coffee fruit from family farms. Unlike synthetic caffeine or isolated extracts, Caffinity delivers a caffeine and polyphenol complex from coffee fruit standardized to 70% natural caffeine and 5% natural polyphenols.

About FutureCeuticals, Inc.

FutureCeuticals, Inc. is the exclusive developer of Caffinity™ and a leader in the research, development and manufacture of plant-based powders and extracts for the functional food, beverage, and dietary supplement markets.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/published-study-shows-clinically-significant-energy-performance-and-metabolic-benefits-of-futureceuticals-caffinity-302795790.html

SOURCE FutureCeuticals, Inc.

Cision PR Newswire

Cision PR Newswire

Related Posts

Utopia Bagels to Receive 2026 Lifetime Achievement Award at New York BagelFest

October 26, 2026

ZINZINO AB (PUBL): Zinzino launches fermented botanical supplements for morning, day and evening

October 26, 2026

SIRHA LYON® 2027: THE WORLD’S LEADING FOODSERVICE EVENT REACHES NEW HEIGHTS FOR ITS 23RD EDITION

October 26, 2026

Monster Energy and Call of Duty® Take Over Cosm Los Angeles for Immersive Modern Warfare® 4 Launch Celebration

October 25, 2026

CARNE Brings a Nightmare Before Christmas to Oxnard with Limited-Time Halloween Pop-Up

October 24, 2026

The Secret to Getting on a New York Wine List? Four Master Sommeliers Come Face to Face with Leading Italian Producers

October 24, 2026

Popular News

  • How to Go 2x Long Anthropic (ANT): Leverage Shares by Themes Explains ANUU, the 2x Leveraged Anthropic ETF Launching Monday

    0 shares
    Share 0 Tweet 0
  • Mendez & Sanchez Finds Three Counties Accounted for Nearly Two-Thirds of California Rideshare Trips

    0 shares
    Share 0 Tweet 0
  • Highmark Health Reports Revenue of $26.5 billion, $741 million in Operating Income, for Nine Months ended Sept. 30, 2026

    0 shares
    Share 0 Tweet 0
  • AZ Blue Health Choice Expands Access to Resources for Page Families

    0 shares
    Share 0 Tweet 0
  • Payoneer Receives OCC Conditional Approval to Form Stablecoin National Trust Bank

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler